An allograft adipose matrix, placed by Dr. Sandhu — the body restoration that doesn’t start with surgery on you.
alloClae™ is an injectable allograft adipose matrix — minimally processed, purified human fat — that restores body volume by prompting your body to regenerate its own adipose tissue over three to six months. Not synthetic filler. Not surgery.

alloClae™ is formulated for the body — hip dips, gluteal projection, breast contour, cleavage, and liposuction irregularities. It adds immediate, targeted volume precisely where fat naturally exists. No liposuction. No fillers. Little downtime. Physician-administered by Dr. Sandhu.

alloClae™ restores body volume by prompting your own fat regeneration — not by adding synthetic material. Reshape, refine, and replace lost volume with results that develop gradually, look and feel like native tissue, and require no surgery or liposuction.









.png)
.png)
Reviewed by Dr. Gurdarshan Sandhu, MD. The honest trade-offs of each approach — so you choose with the full picture.
alloClae™ Allograft adipose matrix | HA filler Synthetic gel | Sculptra / Radiesse Biostimulators | Fat transfer / BBL Surgical grafting | |
|---|---|---|---|---|
| What it is | Intact human adipose tissue — structure and matrix, not synthetic gel | A gel your body absorbs and clears | A stimulant that builds collagen, not volume | Your own fat, surgically harvested and grafted |
| Surgery & anesthesia | None — in-office, topical/local only | None | None | Operating room; local or general anesthesia |
| Downtime | Tenderness 5–7 days; exercise ~2 weeks | 1–2 days | 1–2 days | 2–4+ weeks; compression garment |
| How long it lasts | Immediate volume; integrates as your own tissue over 3–6 months | 6–18 months, then the deficit returns | 1–2 years; multiple sessions | Long-lasting (surviving graft only) |
| The risk you accept | Mild swelling or bruising | Migration; impractical cost at body scale | Slow build; volume ceiling in large zones | Donor-site scar; fat-embolism risk — leading cause of BBL mortality per multi-society advisories |
Comparisons reflect typical outcomes and general characteristics of each approach. Candidacy and individual results are determined at consultation with Dr. Sandhu.

alloClae™ adds immediate, targeted volume that integrates with your tissue, while biostimulators like Sculptra and Radiesse work more slowly by prompting your own collagen. For contour and cushioning in larger body zones, alloClae restores volume directly. Dr. Sandhu will advise which approach — or combination — fits your goal.
Hip dips, upper buttock, breast contour irregularities, cleavage lines, above the knee, and liposuction divots. alloClae™ is large-volume body contouring (12.5 mL and 25 mL syringes), in-office, without general anesthesia.
Hyaluronic filler is absorbed and cleared; the deficit returns when it’s gone. alloClae™ is regenerative — your body replaces the matrix with its own adipose tissue. What remains at six months is your own fat, not a foreign material.
Fat transfer requires liposuction at a donor site — another scar, another recovery. A BBL adds general anesthesia and the FDA black-box fat embolism risk. alloClae™ is off-the-shelf allograft: no harvest, no operating room, same-day return to normal activity.
alloClae™ is regulated by the FDA as a Human Cell and Tissue Product (HCT/P) under 21 CFR Part 1271 — the same framework as skin grafts, corneal transplants, and orthopedic allografts. All donors are screened for communicable disease under federal standards.
Patients who are pregnant, nursing, actively immunocompromised, or who have an active skin infection at the intended treatment zone. Dr. Sandhu finalizes candidacy at consultation after reviewing your full medical history.
Yes. Dr. Sandhu frequently layers regenerative volume with biostimulators (Sculptra, Radiesse), energy-based skin tightening (Fotona, RF microneedling), and targeted neuromodulators. Protocol design is personalized at consultation.